FRNM (Freenome) EV-to-EBIT: (As of Sep. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRNM Freenome Inc FRNM
6 GF Score
Price $16.31
! 2 Warning Signs
View Full Analysis

What is Freenome EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Freenome's Enterprise Value is $1,847.42 Mil. Freenome does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Freenome's EV-to-EBIT at this moment.

The historical rank and industry rank for Freenome's EV-to-EBIT or its related term are showing as below:

FRNM' s EV-to-EBIT Range Over the Past 10 Years
Min: -8.53   Med: 0   Max: 0
Current: -8.53
FRNM's EV-to-EBIT is ranked worse than
100% of 108 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.035 vs FRNM: -8.53

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Freenome's Enterprise Value for the quarter that ended in Dec. 2025 was $0.00 Mil. Freenome does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Freenome's Earnings Yield (Joel Greenblatt) % at this moment.

Freenome  (NAS:FRNM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Freenome's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2025 ) =EBIT / Enterprise Value (Q: Dec. 2025 )
=/0
= %

Freenome EV-to-EBIT Related Terms

Freenome EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Freenome's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Freenome EV-to-EBIT Chart

Freenome Annual Data
Trend Dec24 Dec25
EV-to-EBIT
0.00 0.00

Freenome Semi-Annual Data
Dec24 Dec25
EV-to-EBIT 0.00 0.00

FRNM vs PSNL, OPK, CSTL: EV-to-EBIT Comparison

For the Diagnostics & Research subindustry, Freenome's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Freenome EV-to-EBIT vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Freenome's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Freenome's EV-to-EBIT falls into.


FRNM
6GF Score
Freenome Inc FRNM
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Freenome EV-to-EBIT Calculation

Freenome's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1847.418/
=

Freenome Business Description

Address 3300 Marina Boulevard, Brisbane, CA, USA, Brisbane
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
6GF Score

Get the complete analysis for FRNM

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.31
Price